InvestorsHub Logo
Followers 1055
Posts 189434
Boards Moderated 1
Alias Born 06/19/2009

Re: None

Monday, 08/14/2017 9:01:38 AM

Monday, August 14, 2017 9:01:38 AM

Post# of 3504
8-K, 08/14/17, a strong commitment.
: Yakov Kogan, Ph.D., MBA, Chief Executive Officer, stated, “The pursuit of approval by the EMA and FDA and commercialization for entolimod as a medical radiation countermeasure remains our 
top priority.”
http://www.otcmarkets.com/edgar/GetFilingPdf?FilingID=12230538

My posts are my opinion and should not be used as investment advice. Make your own decisions in your stock trades.